SciELO - Scientific Electronic Library Online

 
vol.24 número1Prevalencia serológica de anticuerpos al virus de la Hepatitis C en personal de salud en el PerúA new technique of laparoscopic surgery for rectal disease índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista de Gastroenterología del Perú

versão impressa ISSN 1022-5129

Resumo

ARBAYZA-AVALOS, Yessenia Katherin; DIAZ-PLASENCIA, Juan Alberto; SEGURA-PLASENCIA, Niler Manuel  e  YAN-QUIROZ, Edgar Fermín. Significancia pronóstica del estadío clínico TNM en la sobrevida quinquenal en carcinoma primario de vesícula biliar. Rev. gastroenterol. Perú [online]. 2004, vol.24, n.1, pp.21-27. ISSN 1022-5129.

PURPOSE. To determine the prognosis significance of the TNM clinic stage and the five-year survival rate of patients with primary carcinoma of the gallbladder. MATERIAL AND METHODS: A descriptive, longitudinal, observational study with a single-box empirical design that evaluated 71 patients with gallbladder cancer who had surgical resection of the neoplasia in the Belén Hospital in Trujillo, Peru between 1966 and 2000. RESULTS: The mean age of the total series was 61.6±12.04 years (ranging from 33 to 88 years). Most of the patients belonged to the age group of 60 years or older (56.3%). Ten patients were males (14.1%) and 61 were females (85.9%), with a M:F ratio of 1:6.1. In the univariate analysis using the log-rank test, the following variables were significantly related to a five-year survival time: primary tumor (p=0.0001), regional ganglionic condition (p=0.0038), clinic stage (p=0.00001). The actuarial survival rate of all the series at 12, 36, and 60 months was 30%, 14.1%, and 11.3%, respectively. CONCLUSIONS: The prognosis factors significantly related to five-year survival were: primary tumor (p=0.0001), regional ganglionic condition (p=0.0038) and clinic stage (p=0.00001). The actuarial survival rate of all the series at 12, 36, and 60 months was 30%, 14.1%, and 11.3%, respectively.

Palavras-chave : Gallbladder carcinoma; TNM; Survival.

        · resumo em Espanhol     · texto em Espanhol